BenevolentAI
BenevolentAI is an AI-enabled drug discovery platform and scientific technology company that unites advanced artificial intelligence, machine learning, and domain-specific science to accelerate the discovery, design, and development of new medicines for complex diseases by making sense of vast, diverse biomedical data and generating actionable scientific insights faster than traditional methods. Its proprietary Benevolent Platform ingests and harmonizes structured and unstructured biomedical information, including literature, genomics, clinical information, and multi-omics data, into a comprehensive knowledge graph, enabling scientists to reason across biological systems, generate hypotheses, predict novel drug targets, and design candidate molecules with higher confidence and lower failure rates.
Learn more
Charlie
Charlie is a sovereign AI scientific agent for researchers and laboratories, specialized in biomedical research and built to accelerate scientific work with precise, sourced answers. It helps users conduct literature reviews, analyze scientific documents, organize research information, and move faster through R&D workflows while keeping traceability at the center of every response. Researchers can ask questions in natural language and get answers extracted directly from scientific documents, with page-level citations that make each source verifiable. Charlie can search simultaneously through hundreds of PDFs, synthesize information, compare articles, understand scientific context, and help users focus on discoveries instead of manual document review. Its research workspace includes libraries, projects, notes, shared collections, PDF reading, highlighting, annotation, and team collaboration, so important passages, references, and insights stay organized across devices.
Learn more
GPT-Rosalind
GPT-Rosalind is a purpose-built frontier reasoning model developed by OpenAI to accelerate scientific research across biology, drug discovery, and translational medicine. It is designed specifically for life sciences workflows, where researchers must navigate large volumes of literature, experimental data, and specialized databases to generate and validate new ideas. It combines deep domain understanding in areas such as chemistry, genomics, protein engineering, and disease biology with advanced tool-use capabilities, allowing it to interact with scientific databases, analyze experimental outputs, and support complex, multi-step reasoning tasks. It can assist with evidence synthesis, hypothesis generation, literature review, sequence interpretation, and experimental planning, helping scientists move faster from raw data to actionable insights. GPT-Rosalind transforms complex, time-intensive research processes into more efficient AI-assisted workflows.
Learn more
FutureHouse
FutureHouse is a nonprofit AI research lab focused on automating scientific discovery in biology and other complex sciences. FutureHouse features superintelligent AI agents designed to assist scientists in accelerating research processes. It is optimized for retrieving and summarizing information from scientific literature, achieving state-of-the-art performance on benchmarks like RAG-QA Arena's science benchmark. It employs an agentic approach, allowing for iterative query expansion, LLM re-ranking, contextual summarization, and document citation traversal to enhance retrieval accuracy. FutureHouse also offers a framework for training language agents on challenging scientific tasks, enabling agents to perform tasks such as protein engineering, literature summarization, and molecular cloning. Their LAB-Bench benchmark evaluates language models on biology research tasks, including information extraction, database retrieval, etc.
Learn more
